Skip to content

Clinical trials

Neoplasms by Site trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms by Site Country / region: Japan Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20131
20162
20172
20192
20202
20213
20221
20233
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting5
Terminated5
Active, not recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Sumitomo Pharma America, Inc.3
AstraZeneca2
Blueprint Medicines Corporation2
Hoffmann-La Roche2
Abbott1
Boston Scientific Corporation1
Bristol-Myers Squibb1
Elevation Oncology1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms by Site20
Neoplasms18
Adenocarcinoma8
Digestive System Neoplasms8
Neoplasms by Histologic Type8
Carcinoma7
Carcinoma, Bronchogenic7
Carcinoma, Non-Small-Cell Lung7
Lung Diseases7
Lung Neoplasms7

Trials

Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.